Pfizer and the University of Wisconsin Form Licensing Agreement
In yet another merger of Big Pharma and academia, two of the world’s leading research entities join forces for combined stem cell R&D.
May 5, 2009
In yet another merger of Big Pharma and academia, two of the world’s leading research entities join forces for combined stem cell R&D.
British scientists turn fetal stem cells into auditory receptors in an animal model.
The Texas Heart Institute in Houston is currently enrolling patients with various cardiovascular conditions for clinical adult stem cell trials.
The National Committee on Bioethics in Seoul has agreed to approve a new embryonic stem cell research project, subject to certain conditions.
Big Pharma and academia team up for a new venture in regenerative medicine.
A group of veterinarians at Cornell University has conducted a controlled study in which autologous adult stem cells were evaluated in the treatment of tendon injuries in horses.